Cornelis, Jurgen http://orcid.org/0000-0002-7124-7727
Barakat, Ansam
Dekker, Jack
Schut, Tessy
Berk, Sandra
Nusselder, Hans
Ruhl, Nikander
Zoeteman, Jeroen
Van, Rien
Beekman, Aartjan
Blankers, Matthijs
Funding for this research was provided by:
Stichting tot Steun Vereniging tot Christelijke Verzorging van Geestes- en Zenuwzieken
Article History
Received: 24 August 2017
Accepted: 12 February 2018
First Online: 27 February 2018
Ethics approval and consent to participate
: - The VUmc medical ethics committee in Amsterdam, the Netherlands gave their medical ethics approval, (# NL55432.029.16).- During the first contact with professionals following the start of a psychiatric crisis patients are randomly allocated to one of the two treatment modalities, IHT or CAU. Written consent to participation in the trial and to treatment allocation will be sought as soon as the psychiatric condition of the patients is stabilized, ultimately 3 weeks after intake. If the patient hesitates about providing informed consent, he will have 5 days to decide about his participation. At admission, and within 24 h after screening and pre-randomisation, the mental competence of the patient to provide informed consent will be assessed using the MacCAT-CR instrument. Only after providing written informed consent, (baseline) measurements are collected by a researcher. If a patient decides not to provide informed consent, he is not included in the study and can receive any treatment deemed necessary.
: N/A
: - The authors declare that they have no conflicts of interest.- The funding body is a non-commercial organisation and there are no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.